Discover 1 curated intelligence briefings related to this specific topic.
As Medicare begins covering GLP-1 weight loss drugs, the ripple effects are hitting unexpected sectors. From a dairy industry unable to scale protein production to a $1 billion monthly cash-pay peptide market, the hunger for metabolic control is rewriting the rules of healthcare and agriculture.
